Piramal Pharma Limited (BOM:543635)

India flag India · Delayed Price · Currency is INR
150.75
+2.00 (1.34%)
At close: Apr 21, 2026
Market Cap200.25B -31.0%
Revenue (ttm)88.71B -0.9%
Net Income-1.64B
EPS-1.24
Shares Outn/a
PE Ration/a
Forward PE85.61
Dividend0.14 (0.09%)
Ex-Dividend DateJul 16, 2025
Volume130,660
Average Volume172,218
Open148.80
Previous Close148.75
Day's Range148.80 - 152.00
52-Week Range132.50 - 228.45
Betan/a
RSI54.15
Earnings DateApr 28, 2026

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje... [Read more]

Industry Pharmaceutical Preparations
Founded 2020
Employees 5,476
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543635
Full Company Profile

Financial Performance

In fiscal year 2025, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.

Financial Statements